About: Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) научна статия (bg) article scientifique (publié 2018) (fr) artigo científico (publicado na 2018) (pt) artículo científico publicado en 2018 (es) im Jahr 2018 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в жовтні 2018 (uk) artículu científicu espublizáu en xineru de 2018 (ast) articolo scientifico (pubblicato il 2018) (it) artikull shkencor i botuar më 01 janar 2018 (sq) scientific article published on 01 January 2018 (en) 2018 թվականին հրատարակված գիտական հոդված (hy)
publication date	wds:Q57808582-BD7677C2-97C9-4F69-B1BB-DA481F607234
publication date	2018-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57808582-84B56D2A-2CCC-4A93-850D-9F1FD4C09446
language of work or name	English
cites work	wds:Q57808582-04AE9809-26C6-4D01-9D2A-519AC4EAE3C5 wds:Q57808582-09ACA2FA-70CC-48AA-8B37-3FDFA4C09D19 wds:Q57808582-117B001E-77DB-4119-8C7C-60556C722ED4 wds:Q57808582-1CD2BA3C-0183-4D77-906B-E21A55D05BC8 wds:Q57808582-1F0DFB88-C1D6-449F-BE1E-94A3504144F9 wds:Q57808582-24ABE2FC-2F04-426B-95AD-8505E68DAFFE wds:Q57808582-2A89E008-005A-493C-A9DF-A543D2466B1D wds:Q57808582-33EFD93F-A41F-4243-9BB2-0830BA1F977E wds:Q57808582-3D7CC910-BCAC-413D-B87F-EE2BDD64728C wds:Q57808582-3D9B4175-8C92-43BA-A319-740FAF22FCBF wds:Q57808582-427FEAFF-B936-49B0-934E-F5727383418D wds:Q57808582-43800BAA-7AC2-416B-9CAC-A332CF8A702B wds:Q57808582-4EFB8165-0B5C-4B7D-AAF7-5793498BE03E wds:Q57808582-64CC7F9C-9569-44B9-846D-C8A7EB9CB974 wds:Q57808582-64DB4CD5-1D8B-4B12-BDF8-D9DABEDEE289 wds:Q57808582-6B6E0DE6-630A-4FA5-9DB2-E4DDC47E7F74 wds:Q57808582-6B83EC60-435E-4DD4-B812-670973671A04 wds:Q57808582-6D1F9931-BC6F-4A09-B3CE-AF9F7B964A41 wds:Q57808582-6F85C021-7FA8-407A-A6CE-34DCE9735A56 wds:Q57808582-78639787-9A8D-4FA4-ACD9-A442596A1E20 wds:Q57808582-7C3C1187-CE9F-49F6-B743-CFFD626D0ADD wds:Q57808582-829EF2DA-9C84-49D7-93BD-F148ED25B0CA wds:Q57808582-A335F688-5CC5-4D19-AC5E-F734E4F7B816 wds:Q57808582-AB28DA36-4A2D-44B5-8853-C8E482FCB81D wds:Q57808582-ACAC57CB-93AF-4006-B851-0630BABBF4D0 wds:Q57808582-AF063705-B4DC-4477-AD0D-957EAD6365E3 wds:Q57808582-B0D7543C-BBD6-4241-BFBE-2845FDEC07C9 wds:Q57808582-B1D5CBB0-76C6-4685-AF2F-E824A6C423A4 wds:Q57808582-BFE1CE36-3D46-406B-896C-F9C601458B07 wds:Q57808582-C17BBB86-670E-4D0E-9F91-0CF5C4442111 wds:Q57808582-C90FE687-0CD1-4000-AE8F-C6B4BC918BF0 wds:Q57808582-EC57B1F0-03C4-4813-8F8A-A6C8D7D46B31 wds:Q57808582-FC1CA30C-DEA5-44CD-85C4-0CB3DBCA25EB wds:Q57808582-FE7E3338-4E7A-4485-9F53-5BAD631C11C8
cites work	Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection Vaccines and vaccination against yellow fever. WHO position paper -- June 2013 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients Immunity to yellow fever nine years after vaccination with 17D vaccine Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil Yellow fever revaccination guidelines change - a decision too feverish? Duration of post-vaccination immunity against yellow fever in adults Long term persistence of yellow fever neutralising antibodies in elderly persons Duration of immunity after yellow fever vaccination Booster dose after 10 years is recommended following 17DD-YF primary vaccination Yellow fever virus: Increasing imported cases in China Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002. Yellow fever cases in French Guiana, evidence of an active circulation in the Guiana Shield, 2017 and 2018 Fatal Yellow Fever in Travelers to Brazil, 2018. Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018. Single shot of 17D vaccine may not confer life-long protection against yellow fever. A fatal case of yellow fever in a European in Uganda. Imported yellow fever in vaccinated tourist Questions regarding the safety and duration of immunity following live yellow fever vaccination Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. Notes from the Field: Fatal Yellow Fever in a Traveler Returning From Peru - New York, 2016. Yellow fever in two unvaccinated French tourists to Brazil, January and March, 2018
author name string	wds:Q57808582-A1FB3E6B-54FB-41D3-AF92-463C471ED0B4 wds:Q57808582-A48DDD5C-92B8-4102-A64B-C596F80865D3
author name string	Corey Fulton Elizabeth R Krow-Lucal
rdfs:label	Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (en) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (nl) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (sq)
skos:prefLabel	Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (en) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (nl) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (sq)
name	Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (en) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (nl) Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (sq)
author	wds:Q57808582-02CA7AB6-1754-4505-820C-35364962CC88 wds:Q57808582-320AFFB4-F031-4AF4-BDCB-3FF631E2A5F8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software